Safety and Efficacy of a Non-Steroidal Anti-Androgen, Based on Results of a Post Marketing Surveillance of Nilutamide

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/sj.pcan.4500516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety and Efficacy of Rapamune® (Sirolimus) in Kidney Transplant Recipients: Results of a Prospective Post-Marketing Surveillance Study in Korea

BMC Nephrology
Nephrology
2018English

Safety and Efficacy Profile of Nano-Formulated, Lower Dose Non-Steroidal Anti-Inflammatory Drugs

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2012English

Safety and Efficacy of Non‐steroidal Anti‐inflammatory Drugs to Reduce Ileus After Colorectal Surgery

British Journal of Surgery
Surgery
2019English

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients

Advances in Therapy
MedicinePharmacology
2020English

Treatment of Comorbid Anxiety and Depression With Escitalopram: Results of a Post-Marketing Surveillance Study

Pharmacopsychiatry
MedicinePsychiatryMental HealthPharmacology
2012English

A Simple Method for Evaluating Analgesic Efficacy of Non-Steroidal Anti-Inflammatory Drugs

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1971English

Safety Profile of Td Vaccination in Indonesian Pregnant Women: A Post-Marketing Surveillance Study

Medical Journal of Indonesia
Medicine
2019English

Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study

Drugs - Real World Outcomes
Pharmacology
2019English

Cardiovascular Safety of Non-Steroidal Anti-Inflammatory Drugs: Network Meta-Analysis

BMJ
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy